Physician|Oncologist by training | ✍️ Aiming for Oncoendocrinology|Narrative writer | 🎨 Acrylic painter #AIIMSNewDelhi #NYMC
New York, USA
Joined September 2022
- Tweets76
- Following447
- Followers174
- Likes171
So excited to share our review article on the rapidly evolving field of Oncoendocrinology. As modern cancer therapies transform survival, recognizing and managing endocrine complications has never been more important, helping patients not just live longer, but live better.
#OncoEndocrinology #Endocrinology #Oncology #CancerSurvivorship #MedTwitter @OncoAlert @TheEndoSociety @sitcancer @immunotherapy @endocrinefeed @endo_fellow @MayoClinicME @Yale @nymedcollege @MDPIOpenAccess
mdpi.com/2076-3271/14/3/347
Sharing my new essay @ Journal of hospital medicine.
Behind every “left AMA” is a story. A young mother with DKA left the ICU not because she ignored the risks, but because her children needed her. A reflection on illness, responsibility, and the human stories behind medical decisions. #NarrativeMedicine #MedTwitter #DKA @TheEndoSociety @nymedcollege @NYCHealthSystem @endocrinefeed
Excited to share that my Google Scholar citations have crossed 3,200! 📚✨
Grateful for the mentors, colleagues, collaborators, and patients who have been part of this journey. Research continues to be one of the most rewarding ways to contribute beyond the bedside.
#AcademicMedicine #MedicalResearch #PhysicianScientist @OncoAlert @TheEndoSociety @nymedcollege
Nidha Iqbal Shapoo retweeted
Honored to receive the Outstanding Abstract Award at #ENDO2026 for presenting the first reported case of Inavolisib-associated diabetic ketoacidosis. Grateful to my mentors, co-authors, and patients who inspire us to keep asking questions and advancing care. #Endocrinology @TheEndoSociety @endocrinefeed @endocrineweb @OncoAlert @Medtwitteer @OncologyTimes @endocrineweb @endo
Honored to receive the Outstanding Abstract Award at #ENDO2026 for presenting the first reported case of Inavolisib-associated diabetic ketoacidosis. Grateful to my mentors, co-authors, and patients who inspire us to keep asking questions and advancing care. #Endocrinology @TheEndoSociety @endocrinefeed @endocrineweb @OncoAlert @Medtwitteer @OncologyTimes @endocrineweb @endo
He was only thirty-one.
A story of youth, illness, and the quiet weight of caring.
Honored to share my latest essay in
Palliative & Supportive Care , Volume 24 , 2026 , e128
DOI: doi.org/10.1017/S14789515261… #palliativecare #Narrativemedicine @oncodaily @CambridgeUP @CambridgeCore @CUPAcademic
doi.org/10.1017/S14789515261…
Excited to share my new reflection.
What does it mean to care for a patient you may never identify?
“Unknown Chicago” reflects on humanity, dignity, and the silent stories we hold in medicine.
doi.org/10.1177/109662182614…
@oncodaily @OncoAlert @PalliativeMed_j @ACEedu @WimedicineOrg @Humanity
Pain is not always visible.
And sometimes, it is not believed.
My new reflection, “The Pain We Don’t Trust,” explores the quiet space between patient suffering and medical skepticism.
#NarrativeMedicine #MedTwitter #PatientVoices @oncodaily
pubmed.ncbi.nlm.nih.gov/4181…
The Other Side of the Table - Nidha Shapoo, 2026 journals.sagepub.com/doi/10.…
Physicians spend years sitting on one side of the table.
Sometimes life teaches us what it means to be on the other.
My narrative essay “The Other Side of the Table” is now published.
A reflection on vulnerability, empathy, and the humanity that lives between doctor and patient.
PMID: 41817203
DOI: 10.1177/10966218261432014
#NarrativeMedicine #MedTwitter #Oncodaily @oncodaily
Solid tumors can drive significant coagulation disorders — from venous & arterial thromboembolism to DIC — worsening outcomes in cancer patients. Better awareness & management strategies needed! @oncodaily @HematologyRepo1
doi.org/10.3390/hematolrep17…
Nidha Iqbal Shapoo retweeted
Four decades later, has small cell lung cancer really changed?
At ILCS 2025, @RManochakian reflected on the long road from platinum-etoposide in the 1980s to today’s standard of chemo-immunotherapy and second-line lurbinectedin. Progress is real, but the story of SCLC still reminds us how far we have to go.
Watch his full talk ⬇️
lungsummit.org/sclc/
AMA poster presentation. Happy to meet a large medical community.
Opioid induced constipation is a crises, sometimes extremely hard to manage leading to complications. Naldemedine can be a life saver. Important topic for all medical specialties.
#MedTwitter #americanmedicalassociation #WashingtonDC #Naldemedine #opioidinducedconstipation @oncodaily @IMG_Oncologists
Nidha Iqbal Shapoo retweeted
How far have we really come in treating small cell lung cancer?
At ILCS 2025, @RManochakian summarized the entire management of SCLC on a single slide: from surgery and chemoradiation in limited-stage disease to first-line chemo-immunotherapy and second-line tarlatamab or lurbinectedin.
Progress is steady, but the fight continues.
Watch his full talk ⬇️
lungsummit.org/sclc/
Nidha Iqbal Shapoo retweeted
🔥🚨#November is 🫁
#LungCancerAwareness Month.
Lung Cancer Awareness #SavesLives.
Together, WITH #Patients, we keep the #Fight against #LungCancer.
We have made a great #Progress but still have a long way to go. #LCAM25
👇🏼Sharing, like every year, my #AWARENESS #Mnemonic
Nidha Iqbal Shapoo retweeted
Glucagon-like peptide-1 receptor agonists (#GLP1s) are associated with a reduced overall #cancer risk in adults with #obesity, lowering the risk for endometrial, ovarian, and meningioma cancers. ja.ma/4nnpTY4
Nidha Iqbal Shapoo retweeted
🚨 ESMO 2025 | LBA15 (AIIMS Delhi)
🧬 Low-dose Pembrolizumab in TNBC
Phase II RCT: Pembrolizumab 50 mg q6wk × 3 + NACT vs NACT alone
👉 pCR 53.8% vs 40.5% (Δ 13.3%, p = 0.047)
➡️ Nearly matches KN-522 results at a fraction of the dose and cost.
💊 Grade ≥ 3 AEs: 50% vs 59.5%
📍Funded by ICMR | Conducted at AIIMS New Delhi
💡 Conclusion: Low-dose pembrolizumab shows comparable efficacy to standard dosing with manageable toxicity.
In LMICs, this could be a viable, affordable immunotherapy pathway.
#ESMO25 @OncoAlert
